Sign in
Taking people in United StatesNo phase

Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study)

Key facts

Who runs it
Midwest Veterans' Biomedical Research Foundation
Where
Kansas City, United StatesSee the site
Trial code
Status
Recruiting
People taking part
36 people, planned
Started
15 Feb 2022
Expected to end
1 Apr 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • ARAT
  • Sham intervention (control)
Record updated
27 February 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (13)Hide the full registry criteria

Who can take part

  • Chronic GERD symptoms (at least 1 typical symptom of GERD, i.e. heartburn or acid reflux/regurgitation at least twice a week) for last 6 months
  • Objective evidence of reflux disease (positive ambulatory pH study.)

Who cannot take part

  • Esophageal stricture with any prior intervention
  • Previous fundoplication, myotomy or LINX surgery
  • Allergic or intolerant to PPI medications
  • Major motility disorder
  • Age <18 years or >80 years
  • Patients unable to or unwilling to participate or consent
  • Large hiatal hernia > 3 cm and Hill grade IV
  • Barrett's esophagus
  • Eosinophilic esophagitis
  • Gastroparesis documented by abnormal gastric emptying time
  • Cirrhosis with esophageal and/or gastric varices

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Gastro esophageal reflux

This trial is currently available in United States.

  • Kansas City VA HospitalKansas City, United StatesContact: April Higbee, BSNTaking people

About the trial

What the trial wants to find out

This will be a randomized clinical trial examining the efficacy and safety of ARAT (intervention group) in patients with chronic GERD symptoms (typical symptoms of GERD, i.e. heartburn or acid reflux/regurgitation at least twice a week) for the last 6 months.

Read full original descriptionShow less

Patients must have a positive pH test and a negative manometry (no treatment) procedure.

The 2 groups in the trial

  • Anti-reflux mucosal ablation (ARAT)Existing treatment, for comparison

    ablation in the gastric cardia using hybrid argon plasma coagulation

    Treatment: ARAT

  • No treatmentSham treatment, for comparison

    no ablation

    Treatment: Sham intervention (control)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)
Criteria questions
Built from NCT05570448, who can take part
Record updated
27 February 2026